Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
Today brought no new treatments, only studies that spot patterns worth watching
-
Nothing today tested a therapy, so treat everything below as a link between things, not proof that one causes the other.
The strongest item today is a data file behind a review, and almost everything else is observational, meaning researchers watched what happened rather than testing a treatment. Much of the day sat outside stage 3 kidney disease too, covering transplant recipients, children, pregnancy, and blood cancer. Two randomized trials did come in, on meditation and on probiotics, but neither included people with kidney disease. Days like this one build background understanding rather than changing what anyone does tomorrow.
Supporting data for: Metabolic Bariatric Surgery as a Bridge to Kidney Transplantation in Patients with Obesity and Advanced Kidney Disease: A Systematic Review and Meta-Analysis
This is the data file behind a review that pooled results from many earlier studies. It looked at weight loss surgery for people with obesity and advanced kidney disease who want a kidney transplant. That question matters because many transplant centers will not list someone above a certain weight. This record holds the raw numbers only, so how much the surgery helped is not stated here.
Demographic and clinical characteristics of rapidly progressive glomerulonephritis in renal vasculitis in the Japan renal biopsy registry
Doctors in Japan pulled cases from a national registry of kidney biopsies, the small tissue samples taken to diagnose kidney disease. They described who gets a fast moving kidney inflammation driven by inflamed blood vessels, and how sick those people were at diagnosis. A registry review like this shows patterns, not cause. The patient counts are in the journal article and are not in this record.
Association of Serum 1,25-Dihydroxyvitamin D Levels with Erythropoietin Resistance Index-Based Relative Erythropoiesis-Stimulating Agent Hyporesponsiveness in Pre-Dialysis Chronic Kidney Disease
Many people with kidney disease get anemia, meaning low red blood cells, and take drugs that push the body to make more. Some people respond poorly to those drugs. This study checked whether a low level of the active form of vitamin D in the blood goes along with that poor response, in people who are not yet on dialysis. It is observational, so it shows a link, not proof that vitamin D is the reason.
Oxidative Stress and Renal Function in Severe Preeclampsia and Normal Pregnancy
This study compared kidney function and signs of cell damage from unstable oxygen molecules in women with severe preeclampsia against women with normal pregnancies. Preeclampsia is dangerous high blood pressure in pregnancy, and it can strain the kidneys. Because the two groups were only compared, this shows a link, not proof that the cell damage causes the kidney changes. No abstract was available, so the number of women studied is not known from this record.
Metal Homeostasis Imbalance as Potentially Contributing Mechanism in Onset of Cardiac Disorders in Individuals with Chronic Obstructive Pulmonary Disease and Chronic Kidney Disease
This study looked at whether an imbalance of metals in the body, things like zinc, copper and iron, is linked to heart problems in people who have both chronic lung disease and chronic kidney disease. Damaged kidneys struggle to keep these metals in balance. The work shows an association only, not proof that metal imbalance causes the heart trouble. No abstract was available, so the size of the study is not known from this record.
Association of adverse adulthood experiences with cardiovascular kidney metabolic syndrome
This study looked at hard experiences in adult life, such as abuse, money trouble, or losing a home. It checked whether people who went through more of them were more likely to have cardiovascular kidney metabolic syndrome, a cluster of heart, kidney, and blood sugar problems that travel together. The design is observational, so it shows a link, not proof that stress causes the syndrome. The size of that link is in the full article, not in this record.
A Circulating Proteomic Signature of Allostatic Load Is Associated with Multisystem Disease and Mortality
Researchers found a pattern of proteins in the blood that tracks with allostatic load, which is the wear and tear the body takes from long-term stress. People with that protein pattern were more likely to have disease in several organ systems and more likely to die during follow-up. This is an observational study, so it shows a link, not proof that stress caused the illness. People who are already sick can have both higher stress and these protein changes.
Clinical implications of cardiovascular events in older kidney transplant recipients: a nationwide cohort study
This nationwide study followed older adults who received a kidney transplant and tracked heart problems such as heart attacks and strokes. The aim was to see what those events mean for how long people live and how the new kidney holds up. It is an observational cohort, so it shows a link, not proof of cause. This record is the supporting data deposit, so the numbers are not written out here.
Performance of the iBox Prognostication System in African American Kidney Transplant Recipients
The iBox is a calculator that predicts how long a transplanted kidney will keep working. This study checked how well it performs in African American transplant recipients, a group that has worse transplant outcomes on average. The study looked back at patient records rather than testing anything, so it shows how well the tool matched what happened, not why. If the tool is less accurate in this group, it could shape who gets closer follow-up.
Perceived Child Vulnerability and Protective Behavior by Parents of Children with Chronic Kidney Disease
Researchers asked parents of children with long term kidney disease how fragile they believe their child to be. They then looked at whether that belief changes how protective the parents act day to day. This is an observational study, so it shows a link, not proof that one causes the other. The counts and results sit in the journal article and are not in this record.
Patient-reported ratings of transfer to adult care among young adults with chronic kidney disease
Young adults with chronic kidney disease were asked to rate how their move from children's care to adult care went. This handoff is a known weak point, and young people often lose track of care around it. The report is based on what patients said about their own experience, so it describes the problem and shows links, not causes. It is a repository posting, not a peer reviewed journal article.
Chronic Kidney Disease and Clinical Outcomes in Patients With Multiple Myeloma: A Multicenter Real-World Cohort Study
This study followed people with multiple myeloma, a blood cancer, across several hospitals and compared those who also had chronic kidney disease. Myeloma often damages the kidneys, and this work tracks how those patients did. It is observational, so it shows a link between kidney disease and worse outcomes, not proof that one caused the other. No abstract was available, so how many people were included and how long they were followed is not known from this record.
Blood pressure and cardiovascular risk in adults with non-proteinuric chronic kidney disease without diabetes.
This Japanese study followed 287,238 adults with reduced kidney filtering rate (eGFR under 60) who had no diabetes and little or no protein in their urine. It compared blood pressure levels against later heart attacks, strokes, and other heart problems. Both high blood pressure and unusually low blood pressure tracked with more heart events in this group. The study watched what happened in real life rather than assigning treatment, so it shows a link, not proof that the blood pressure itself caused the harm.
The SGLT2i Treatment Gap in UK Primary Care: A Cross-Sectional RWE Study of Prescribing in Clinical Practice.
This UK study looked at family doctor records to count people who qualify for SGLT2 inhibitors but are not taking them. These are pills that protect the kidneys and heart in type 2 diabetes, chronic kidney disease, and heart failure. It found that use in UK primary care falls well short of what guidelines recommend, leaving a large untreated group. This is a snapshot of prescribing, not a test of the drugs, so it shows a gap in care rather than proving what causes it.
Nephroprotective Effects of Carvedilol and Sodium Copper Chlorophyllin in Glycerol-Induced Acute Kidney Injury in Female Rats
Researchers gave female rats carvedilol, a blood pressure drug, and sodium copper chlorophyllin, a chlorophyll-based compound, before causing sudden kidney injury with glycerol. Both treatments appeared to protect the rats' kidneys from that damage. This was done in animals, not people. Sudden kidney injury in rats is also not the same as slow kidney disease in humans, so this is an early lead only.
Apelin-13 Pretreatment Attenuates Age-Associated Renal Fibrotic Remodeling Following I/R Injury
Apelin-13 is a small natural peptide. Giving it before cutting off and then restoring blood flow to the kidney reduced the scarring that followed in older animals. Scarring is what turns a one-time kidney injury into permanent loss of function, and older kidneys scar more. This was done in animals, not people, and the drug was given before the injury, which is rarely possible in real life.
Dapagliflozin inhibits renal mesangial cell fibrosis by regulating HO-1/TGF-β1/Smad 2/3 axis.
This lab study tested dapagliflozin, an SGLT2 inhibitor already used in kidney disease, on kidney cells to work out how it reduces scarring. Scarring is the stiff tissue that builds up and gradually destroys filtering units. The researchers traced the effect to a specific chemical signaling chain inside the cell. This was done in cells, not in people, so it explains a possible mechanism behind a drug that already has human evidence.
Tailored B-cell monitoring in podocytopathies: a necessary shift in practice
This is an opinion piece arguing that doctors should track B cells, a type of immune cell, more closely in podocytopathies. Podocytopathies are kidney diseases that damage the filter cells in the kidney and let protein leak into the urine. Drugs that wipe out B cells are used to treat them, and the authors want the monitoring tailored to each patient instead of one fixed schedule. It is a call to change practice, not a study, so there are no results yet.
What are the latest guidelines for hyperkalaemia in adults?
This is a short guideline summary on treating high blood potassium, called hyperkalaemia, in adults. High potassium is a common and dangerous problem in kidney disease, because damaged kidneys clear less potassium from the blood. It is also the reason some kidney protecting drugs get stopped or cut back. The piece explains current advice and reports no new study results.
Hyperglycaemia-induced molecular reprogramming of proximal tubular epithelial cells and its contribution to diabetic kidney disease progression—a narrative review
This is a review article, not a new study. It walks through how high blood sugar changes the cells lining the kidney's small tubes, and how those changes push diabetic kidney disease forward. It gathers existing laboratory findings and reports no new results of its own. Useful as background on the biology, but nothing here changes treatment.